Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.
Press releases published on May 7, 2025

SCR Partners Appoints Lisa Kampf as Senior Vice President as the Company Broadens Financial and Strategic Communications Offering
NASHVILLE, Tenn., May 07, 2025 (GLOBE NEWSWIRE) -- SCR Partners, LLC, a leading strategic advisory firm, today announced the appointment of Lisa Kampf as Senior Vice President, reinforcing the firm’s growing platform of financial and strategic …

Aki Yorihiro Discusses Fast Motion Shaft Breakthrough on TechMediaWire Podcast
AUSTIN, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The TechMediaWire …

RENEW Energy Partners Named 2025 Climate Finance Innovator by U.S. Department of Energy Better Buildings Initiative
BOSTON, May 07, 2025 (GLOBE NEWSWIRE) -- RENEW Energy Partners has been named a 2025 Climate Finance Innovator Award recipient by the U.S. Department of Energy’s Better Buildings Initiative. This annual award recognizes organizations pioneering new …

Big Screen Entertainment Group Expands Global Distribution on Amazon
LOS ANGELES, May 07, 2025 (GLOBE NEWSWIRE) -- Big Screen Entertainment Group (OTC:BSEG) is proud to announce a major expansion of its global distribution reach with Amazon, making its growing library of content available to audiences in multiple countries …

Risk Strategies Annual Education Practice Student Health Plan Survey Finds Costs Rising Nationwide
BOSTON, May 07, 2025 (GLOBE NEWSWIRE) -- Risk Strategies, a leading national specialty insurance brokerage and risk management and consulting firm, today released the findings of its Annual Student Health Plan Benchmarking Survey. For the fourth …

Giants of Cancer Care® announces the 13th annual class of inductees
WASHINGTON, May 07, 2025 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals and Pfizer (platinum supporter), DSI (platinum supporter) and Regeneron (silver supporter), are thrilled to announce the inductees of …

MKS Breaks Ground on New Chemical Manufacturing and TechCenter Facility in Thailand
ANDOVER, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- MKS Instruments. Inc. (NASDAQ: MKSI) (“MKS”), a global provider of enabling technologies that transform our world, announced today the groundbreaking of its cutting-edge Atotech chemical manufacturing and …

IBCAP Announces $25 Million Copyright Infringement Lawsuit against UK-based Hosting Provider Innetra PC
DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- The International Broadcaster Coalition Against Piracy (IBCAP) today announced a $25 million complaint filed in the U.S. District Court for the Northern District of California against Innetra PC, a U.K.-based …

Alkeus Pharmaceuticals Presents Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced additional data from its Phase 2 clinical study ( …

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present at the Bank of America Securities 2025 …

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Christopher Schaber, CEO of Soligenix Inc.
AUSTIN, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast …

Future Today Takes Center Stage at IAB NewFronts 2025
Future Today Expands Fawesome’s Premium Content Portfolio with partnerships with Gusto TV, Pangea Entertainment and Bold Baking Network Launch of Chuck E. Cheese Media Network to Deliver Content on HappyKids and Standalone FAST App Powering Privacy-Safe, …

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of …

Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPP Plan to initiate Phase 2 study of DISC-3405 in …

XYZ Media’s “Next Generation of Innovators” Series Spotlights Aidan Cao for His Pinecone-Inspired Hygrobots for Biomedical Applications
LOS ANGELES, May 07, 2025 (GLOBE NEWSWIRE) -- XYZ Media, a leading media company that bridges educational pursuits with technological innovation, is pleased to announce a new season of its “Next Generation of Innovators” series, a digital campaign that …

Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
In line with recent FDA feedback, Seres expects to submit a Phase 2 study protocol to FDA in the coming weeks for SER-155 for the prevention of bloodstream infections (BSIs) in adults undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT) for …

Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
Worldwide revenue of $372.8 million in the first quarter 2025 GAAP fully diluted earnings per share of $1.02, compared to $1.87 in the first quarter of 2024; adjusted fully diluted earnings per share of $1.53, compared to $1.69 in the first quarter of 2024 …

Vigil Neuroscience Reports First Quarter 2025 Financial Results and Provides Recent Business Updates
– On track to report final analysis from IGNITE Phase 2 clinical trial evaluating iluzanebart in ALSP in Q2 2025 – – Plans to initiate Phase 2 clinical trial evaluating VG-3927 in Alzheimer’s disease in Q3 2025 – WATERTOWN, Mass., May 07, 2025 (GLOBE …

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update
-- First quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $37.7 million -- -- Setmelanotide pivotal Phase 3 TRANSCEND trial met primary endpoint with -19.8% placebo-adjusted BMI reduction in patients (N=120) with acquired …

C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
Updated Cemsidomide Multiple Myeloma Data Further Demonstrate Compelling Response Rates at Multiple Doses and Potential for Best-in-Class Profile; 50% ORR Observed at the Highest Dose Level of 100 µg, Including One Patient With a Minimal Residual Disease …